KAREN DOLEZAL: Open Payments
NPI 1649702267 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,471 in 66 payments from 21 companies in 2025. Trend: 2023 $2,290 · 2024 $3,177 · 2025 $1,471
Food & beverage: $1,471
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $309 |
| Axsome Therapeutics, Inc. | 5 | $202 |
| Amgen Inc. | 7 | $120 |
| Abbott Laboratories | 4 | $95 |
| E.R. Squibb & Sons, L.L.C. | 5 | $86 |
| Philips North America LLC | 3 | $77 |
| Alnylam Pharmaceuticals Inc. | 3 | $72 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $67 |
| SCPHARMACEUTICALS INC. | 3 | $63 |
| Esperion Therapeutics, Inc. | 3 | $58 |
Products named: LEQVIO, REPATHA, Auvelity, Sunosi, ONPATTRO, JOT DX, LifeVest, FUROSCIX.
Industry payments across SC — which companies pay providers there.
